Autism and oxytocin

New developments in translational approaches to therapeutics

Joshua J. Green, Eric Hollander

Research output: Contribution to journalArticle

79 Citations (Scopus)

Abstract

Autism is a neurodevelopmental disorder characterized by dysfunction in three core symptom domains: speech and communication deficits, repetitive or compulsive behaviors with restricted interests, and social impairment. The neuropeptide oxytocin, along with the structurally similar peptide arginine vasopressin, may play a role in the etiology of autism, and especially in the social impairment domain. Oxytocin is a nonapeptide (i.e., it has nine amino acids). It is synthesized in magnocellular neurons in the paraventricular nucleus and the supraoptic nucleus of the hypothalamus and is released into the bloodstream by way of axon terminals in the posterior pituitary. Oxytocin is released both peripherally, where it is involved in milk letdown and the facilitation of uterine contractions, and centrally, where it acts as a neuromodulator along with arginine vasopressin. Here, we discuss relevant translational research pertaining to the role of oxytocin in social and repetitive behaviors and consider clinical implications. We also discuss current research limitations, review recent preliminary findings from studies involving oxytocin in autism spectrum disorder patient populations, and point to possible directions for future research.

Original languageEnglish (US)
Pages (from-to)250-257
Number of pages8
JournalNeurotherapeutics
Volume7
Issue number3
DOIs
StatePublished - Jul 2010

Fingerprint

Oxytocin
Autistic Disorder
Arginine Vasopressin
Compulsive Behavior
Therapeutics
Supraoptic Nucleus
Uterine Contraction
Translational Medical Research
Paraventricular Hypothalamic Nucleus
Presynaptic Terminals
Neuropeptides
Neurotransmitter Agents
Milk
Communication
Neurons
Amino Acids
Peptides
Research
Population

Keywords

  • Arginine vasopressin
  • ASD
  • Autism
  • Epigenetic
  • Oxytocin
  • Repetitive behavior
  • Social behavior
  • Social cognition
  • Social functioning
  • Therapeutics
  • Translational model

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Clinical Neurology
  • Pharmacology
  • Medicine(all)

Cite this

Autism and oxytocin : New developments in translational approaches to therapeutics. / Green, Joshua J.; Hollander, Eric.

In: Neurotherapeutics, Vol. 7, No. 3, 07.2010, p. 250-257.

Research output: Contribution to journalArticle

@article{7150214fa3784b2289a7dca56bcd1fba,
title = "Autism and oxytocin: New developments in translational approaches to therapeutics",
abstract = "Autism is a neurodevelopmental disorder characterized by dysfunction in three core symptom domains: speech and communication deficits, repetitive or compulsive behaviors with restricted interests, and social impairment. The neuropeptide oxytocin, along with the structurally similar peptide arginine vasopressin, may play a role in the etiology of autism, and especially in the social impairment domain. Oxytocin is a nonapeptide (i.e., it has nine amino acids). It is synthesized in magnocellular neurons in the paraventricular nucleus and the supraoptic nucleus of the hypothalamus and is released into the bloodstream by way of axon terminals in the posterior pituitary. Oxytocin is released both peripherally, where it is involved in milk letdown and the facilitation of uterine contractions, and centrally, where it acts as a neuromodulator along with arginine vasopressin. Here, we discuss relevant translational research pertaining to the role of oxytocin in social and repetitive behaviors and consider clinical implications. We also discuss current research limitations, review recent preliminary findings from studies involving oxytocin in autism spectrum disorder patient populations, and point to possible directions for future research.",
keywords = "Arginine vasopressin, ASD, Autism, Epigenetic, Oxytocin, Repetitive behavior, Social behavior, Social cognition, Social functioning, Therapeutics, Translational model",
author = "Green, {Joshua J.} and Eric Hollander",
year = "2010",
month = "7",
doi = "10.1016/j.nurt.2010.05.006",
language = "English (US)",
volume = "7",
pages = "250--257",
journal = "Neurotherapeutics",
issn = "1933-7213",
publisher = "Springer New York",
number = "3",

}

TY - JOUR

T1 - Autism and oxytocin

T2 - New developments in translational approaches to therapeutics

AU - Green, Joshua J.

AU - Hollander, Eric

PY - 2010/7

Y1 - 2010/7

N2 - Autism is a neurodevelopmental disorder characterized by dysfunction in three core symptom domains: speech and communication deficits, repetitive or compulsive behaviors with restricted interests, and social impairment. The neuropeptide oxytocin, along with the structurally similar peptide arginine vasopressin, may play a role in the etiology of autism, and especially in the social impairment domain. Oxytocin is a nonapeptide (i.e., it has nine amino acids). It is synthesized in magnocellular neurons in the paraventricular nucleus and the supraoptic nucleus of the hypothalamus and is released into the bloodstream by way of axon terminals in the posterior pituitary. Oxytocin is released both peripherally, where it is involved in milk letdown and the facilitation of uterine contractions, and centrally, where it acts as a neuromodulator along with arginine vasopressin. Here, we discuss relevant translational research pertaining to the role of oxytocin in social and repetitive behaviors and consider clinical implications. We also discuss current research limitations, review recent preliminary findings from studies involving oxytocin in autism spectrum disorder patient populations, and point to possible directions for future research.

AB - Autism is a neurodevelopmental disorder characterized by dysfunction in three core symptom domains: speech and communication deficits, repetitive or compulsive behaviors with restricted interests, and social impairment. The neuropeptide oxytocin, along with the structurally similar peptide arginine vasopressin, may play a role in the etiology of autism, and especially in the social impairment domain. Oxytocin is a nonapeptide (i.e., it has nine amino acids). It is synthesized in magnocellular neurons in the paraventricular nucleus and the supraoptic nucleus of the hypothalamus and is released into the bloodstream by way of axon terminals in the posterior pituitary. Oxytocin is released both peripherally, where it is involved in milk letdown and the facilitation of uterine contractions, and centrally, where it acts as a neuromodulator along with arginine vasopressin. Here, we discuss relevant translational research pertaining to the role of oxytocin in social and repetitive behaviors and consider clinical implications. We also discuss current research limitations, review recent preliminary findings from studies involving oxytocin in autism spectrum disorder patient populations, and point to possible directions for future research.

KW - Arginine vasopressin

KW - ASD

KW - Autism

KW - Epigenetic

KW - Oxytocin

KW - Repetitive behavior

KW - Social behavior

KW - Social cognition

KW - Social functioning

KW - Therapeutics

KW - Translational model

UR - http://www.scopus.com/inward/record.url?scp=77954944264&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954944264&partnerID=8YFLogxK

U2 - 10.1016/j.nurt.2010.05.006

DO - 10.1016/j.nurt.2010.05.006

M3 - Article

VL - 7

SP - 250

EP - 257

JO - Neurotherapeutics

JF - Neurotherapeutics

SN - 1933-7213

IS - 3

ER -